Immunobiomarkers in Small Cell Lung Cancer: Potential Early Cancer Signals
暂无分享,去创建一个
Andrea Murray | Jared Allen | J. Robertson | A. Murray | C. Chapman | Jared Allen | A. Thorpe | P. Maddison | John F R Robertson | A. Chauhan | Caroline J Chapman | Alison J Thorpe | Celine B Parsy-Kowalska | Kelly M Stafford | Alok S Chauhan | Thomas A Kite | Paul Maddison | T. Kite | Celine B. Parsy-Kowalska | K. Stafford
[1] J. Robertson,et al. Autoantibodies in breast cancer: their use as an aid to early diagnosis. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.
[2] S. Duffy,et al. Lung cancer screening: the way forward , 2008, British Journal of Cancer.
[3] A. Nicholson,et al. The Role of Surgery in the Treatment of Limited Disease Small Cell Lung Cancer: Time to Reevaluate , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[4] Ugur Sahin,et al. Humoral immune responses of lung cancer patients against tumor antigen NY-ESO-1. , 2006, Cancer letters.
[5] J. Robertson,et al. Autoimmunity to SOX2, clinical phenotype and survival in patients with small-cell lung cancer. , 2010, Lung cancer.
[6] A. Twijnstra,et al. SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] A Murray,et al. Autoantibodies in lung cancer: possibilities for early detection and subsequent cure , 2007, Thorax.
[8] B. Lang,et al. Paraneoplastic neurological autoimmunity and survival in small-cell lung cancer , 2008, Journal of Neuroimmunology.
[9] N. Malats,et al. Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] C. D'Orsi,et al. Diagnostic Performance of Digital Versus Film Mammography for Breast-Cancer Screening , 2005, The New England journal of medicine.
[11] P. Boyle,et al. Clinical validation of an autoantibody test for lung cancer , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[12] A. Chuchalin,et al. Recoverin as a paraneoplastic antigen in lung cancer: the occurrence of anti-recoverin autoantibodies in sera and recoverin in tumors. , 2004, Lung cancer.
[13] D. Jackman,et al. Small-cell lung cancer , 2005, The Lancet.
[14] Jacqueline Palace,et al. Incidence of serum anti-P/Q-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome , 1997, Journal of the Neurological Sciences.
[15] J. Herman,et al. Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: Its time has come. , 2005, The Journal of thoracic and cardiovascular surgery.
[16] Edward L Spitznagel,et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] A. Stromberg,et al. Profiling Tumor-Associated Antibodies for Early Detection of Non-small Cell Lung Cancer , 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[18] Mithat Gonen,et al. Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters , 2005, Cancer.
[19] B. Stewart,et al. World Cancer Report , 2003 .
[20] E. Apostolakis,et al. Current role of surgery in small cell lung carcinoma , 2009, Journal of cardiothoracic surgery.
[21] P. Kvale,et al. Update in screening of lung cancer , 2005, Respirology.
[22] G. Cooper,et al. The epidemiology of autoimmune diseases. , 2003, Autoimmunity reviews.
[23] S. London,et al. Low level anti-Hu reactivity: A risk marker for small cell lung cancer? , 2009, Cancer detection and prevention.
[24] P. Boyle,et al. World Cancer Report 2008 , 2009 .
[25] J. Jett,et al. Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[26] D. Pim,et al. Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer , 1982, International journal of cancer.
[27] J. Robertson,et al. Two-step method to isolate target recombinant protein from co-purified bacterial contaminant SlyD after immobilised metal affinity chromatography. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[28] S. Hanash,et al. Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] E. Tan. Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis. , 2001, The Journal of clinical investigation.
[30] Lars Alfredsson,et al. Smoking as a trigger for inflammatory rheumatic diseases , 2007, Current opinion in rheumatology.
[31] C. Begg,et al. Variations in lung cancer risk among smokers. , 2003, Journal of the National Cancer Institute.
[32] Jian-ying Zhang. Tumor-associated antigen arrays to enhance antibody detection for cancer diagnosis. , 2004, Cancer detection and prevention.
[33] R. Stahel,et al. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC). , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.
[34] J. Goudevenos,et al. High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population. , 1987, Clinical and experimental immunology.
[35] S. Pinder,et al. Autoantibodies in early breast cancer , 2005 .
[36] Matthew B Schabath,et al. A risk model for prediction of lung cancer. , 2007, Journal of the National Cancer Institute.
[37] Shotai Kobayashi,et al. Antinuclear antibodies in healthy aging people: a prospective study , 1995, Mechanisms of Ageing and Development.
[38] C. Caruso,et al. Prevalence of organ-specific and non organ-specific autoantibodies in healthy centenarians , 1997, Mechanisms of Ageing and Development.
[39] K. Hemminki,et al. p53 autoantibodies predict subsequent development of cancer , 2005, International journal of cancer.
[40] G. Kalemkerian,et al. Small cell lung cancer , 2010, Seminars in Respiratory and Critical Care Medicine.
[41] J. Koziol,et al. Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[42] J. Robertson,et al. Technical validation of an autoantibody test for lung cancer , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.